Methods and reagents for the treatment of inflammatory...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/56 (2006.01) A61K 31/137 (2006.01) A61K 31/58 (2006.01) A61P 29/00 (2006.01) G01N 33/15 (2006.01)

Patent

CA 2545615

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a tricyclic compound and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing a tricyclic compound and a corticosteroid or other compound for the treatment or prevention of an immunoinflammatory disorder.

La présente invention a trait à un procédé pour le traitement d'un patient diagnostiqué comme étant atteint d'un trouble immunoinflammatoire, ou à risque de le développer, par l'administration d'un composé tricyclique et, éventuellement, un corticostéroïde ou un autre composé au patient. L'invention a également trait à une composition pharmaceutique contenant un composé tricyclique et un corticostéroïde ou un autre composé pour le traitement ou la prévention d'un trouble immunoinflammatoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and reagents for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and reagents for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and reagents for the treatment of inflammatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1874354

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.